- Home
- CMPX vs SPCE Comparison
CMPX vs SPCE Comparison
Compare CMPX & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- SPCE
- Stock Information
- Founded
- CMPX 2014
- SPCE 2017
- Country
- CMPX United States
- SPCE United States
- Employees
- CMPX N/A
- SPCE N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- SPCE Transportation Services
- Sector
- CMPX Health Care
- SPCE Consumer Discretionary
- Exchange
- CMPX Nasdaq
- SPCE Nasdaq
- Market Cap
- CMPX 217.4M
- SPCE 166.3M
- IPO Year
- CMPX N/A
- SPCE N/A
- Fundamental
- Price
- CMPX $1.59
- SPCE $6.46
- Analyst Decision
- CMPX Strong Buy
- SPCE Hold
- Analyst Count
- CMPX 2
- SPCE 6
- Target Price
- CMPX $9.00
- SPCE $31.50
- AVG Volume (30 Days)
- CMPX 366.4K
- SPCE 1.2M
- Earning Date
- CMPX 11-07-2024
- SPCE 11-06-2024
- Dividend Yield
- CMPX N/A
- SPCE N/A
- EPS Growth
- CMPX N/A
- SPCE N/A
- EPS
- CMPX N/A
- SPCE N/A
- Revenue
- CMPX $850,000.00
- SPCE $10,742,000.00
- Revenue This Year
- CMPX N/A
- SPCE N/A
- Revenue Next Year
- CMPX $950.68
- SPCE N/A
- P/E Ratio
- CMPX N/A
- SPCE N/A
- Revenue Growth
- CMPX N/A
- SPCE 175.51
- 52 Week Low
- CMPX $0.77
- SPCE $5.27
- 52 Week High
- CMPX $2.34
- SPCE $54.60
- Technical
- Relative Strength Index (RSI)
- CMPX 64.03
- SPCE 48.77
- Support Level
- CMPX $1.42
- SPCE $5.75
- Resistance Level
- CMPX $1.65
- SPCE $6.84
- Average True Range (ATR)
- CMPX 0.13
- SPCE 0.37
- MACD
- CMPX 0.01
- SPCE 0.05
- Stochastic Oscillator
- CMPX 66.01
- SPCE 44.76
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.